Skip to main content
. Author manuscript; available in PMC: 2012 Aug 15.
Published in final edited form as: Clin Cancer Res. 2011 Jul 7;17(16):5473–5480. doi: 10.1158/1078-0432.CCR-11-0774

Figure 3.

Figure 3

Overall Survival by CD4 Count at 2 Months

Legend for Figure 3: Survival in patients with CD4 counts <200 cells/mm3 at two months was substantially different from those with higher CD4 counts as measured by median survival (13.1 months (95% CI: 9.1–16.4) versus to 19.7 months (95% CI: 15.9–24.0)), log rank test (p=0.002, log-rank test), or the adjusted hazard ratio for death (1.66 (p=0.03)).